Beijing Strong Biotechnologies,Inc. (SHE:300406)
China · Delayed Price · Currency is CNY 13.27
+0.11 (0.84%)
Feb 4, 2026, 2:45 PM CST
SHE:300406 Revenue
Beijing Strong Biotechnologies,Inc. had revenue of 343.38M CNY in the quarter ending September 30, 2025, a decrease of -17.39%. This brings the company's revenue in the last twelve months to 1.43B, down -17.88% year-over-year. In the year 2024, Beijing Strong Biotechnologies,Inc. had annual revenue of 1.66B, down -4.75%.
Revenue (ttm)
1.43B
Revenue Growth
-17.88%
P/S Ratio
5.37
Revenue / Employee
1.31M
Employees
1,098
Market Cap
7.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.66B | -82.69M | -4.75% |
| Dec 31, 2023 | 1.74B | 230.75M | 15.27% |
| Dec 31, 2022 | 1.51B | -88.51M | -5.53% |
| Jan 1, 2022 | 1.60B | 751.27M | 88.58% |
| Dec 31, 2020 | 848.12M | 7.26M | 0.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 10.50B |
| Shanghai Runda Medical Technology | 7.40B |
| Guangzhou Kingmed Diagnostics Group | 6.11B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.13B |
| Berry Genomics Co.,Ltd | 941.16M |